DadFinStart your free week
DadFin › Stocks › Financial Services › ECPG

Encore Capital Group, Inc. (ECPG) stock score

Financial Services · Credit Services · United States

$99.77 ▼ -0.29% today

95.1
Dad Score, out of 100
strong

Encore Capital Group, Inc. (ECPG) is a Credit Services company in the Financial Services sector, listed in the United States. On DadFin's weekly run it scores 95.1 out of 100 on the Dad Score, a strong reading that places the business ahead of 95% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Financial Services it ranks #91 of 1,228. Its strongest axes are valuation, quality and growth; its weakest is risk.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Above average
Quality
Strong
Growth
Strong
Price action
Above average
Risk
Weak
Conviction
Strong
Liquidity
Above average
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)7.3×
P/E (forward)7.2×
Dividend yield0.00%
Return on capital12.1%
Operating margin38.0%
Revenue growth (YoY)+34.4%
FCF yield2.2%
Net debt / EBITDA5.37×
Piotroski F-Score7 / 9
52-week change+136.1%
Market cap$2.0B
Next earningsNov 4, 2026

What subscribers see on ECPG

Start your free weekSubscriber? Open the full research →

Credit Services peers

StockCompanyDad ScoreBandMarket cap
VVisa Inc.44.8middling$677.1B
MAMastercard Incorporated59.3middling$483.8B
AXPAmerican Express Company83.6good$204.5B
COFCapital One Financial Corporation99.8strong$119.5B
PYPLPayPal Holdings, Inc.73.4good$45.5B
AFRMAffirm Holdings, Inc.56.3middling$23.9B
SYFSynchrony Financial58.0middling$23.4B
SOFISoFi Technologies, Inc.53.8middling$20.4B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.